Document ID: FDA-2015-F-4282-0001
Agency: fda
Document Type: Proposed Rule
Title: BASF Corp.; Filing of Food Additive Petition (Animal Use)
Posted Date: 2015-11-24T05:00Z

[Federal Register Volume 80, Number 226 (Tuesday, November 24, 2015)]
[Proposed Rules]
[Page 73153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29832]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 573

[Docket No. FDA-2015-F-4282]

BASF Corp.; Filing of Food Additive Petition (Animal Use)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of petition.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that BASF 
Corp. has filed a petition proposing that the food additive regulations 
be amended to provide for the safe use of sodium formate as a feed 
acidifier in poultry feed.

DATES: The food additive petition was filed on October 15, 2015.

FOR FURTHER INFORMATION CONTACT: Chelsea Trull, Center for Veterinary 
Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, 
MD 20855, 240-402-6729, chelsea.trull@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (section 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a 
food additive petition (FAP 2293) has been filed by BASF Corp., 100 
Park Ave., Florham Park, NJ 07932. The petition proposes to amend the 
food additive regulations in 21 CFR part 573 Food Additives Permitted 
in Feed and Drinking Water of Animals to provide for the safe use of 
sodium formate as a feed acidifier in poultry feed.
    The petitioner has claimed that this action is categorically 
excluded under 21 CFR 25.32(r) because it is of a type that does not 
individually or cumulatively have a significant effect on the human 
environment. In addition, the petitioner has stated that to their 
knowledge, no extraordinary circumstances exist. If FDA determines a 
categorical exclusion applies, neither an environmental assessment nor 
an environmental impact statement is required. If FDA determines a 
categorical exclusion does not apply, we will request an environmental 
assessment and make it available for public inspection.

    Dated: November 18, 2015.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2015-29832 Filed 11-23-15; 8:45 am]
BILLING CODE 4164-01-P